Cargando…

Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study

Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lina, Liu, Maochang, Qin, Weiwei, Shi, Dandan, Mao, Junjun, Li, Zeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587682/
https://www.ncbi.nlm.nih.gov/pubmed/37869748
http://dx.doi.org/10.3389/fphar.2023.1228641
_version_ 1785123420384526336
author Zhang, Lina
Liu, Maochang
Qin, Weiwei
Shi, Dandan
Mao, Junjun
Li, Zeyun
author_facet Zhang, Lina
Liu, Maochang
Qin, Weiwei
Shi, Dandan
Mao, Junjun
Li, Zeyun
author_sort Zhang, Lina
collection PubMed
description Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predictive abilities of pediatric popPK models of VPA and identified the potential effects of protein binding modeling strategies. Methods: A dataset of 255 trough concentrations in 202 children with epilepsy was analyzed to assess the predictive performance of qualified models, following literature review. The evaluation of external predictive ability was conducted by prediction- and simulation-based diagnostics as well as Bayesian forecasting. Furthermore, five popPK models with different protein binding modeling strategies were developed to investigate the discrepancy among the one-binding site model, Langmuir equation, dose-dependent maximum effect model, linear non-saturable binding equation and the simple exponent model on model predictive ability. Results: Ten popPK models were identified in the literature. Co-medication, body weight, daily dose, and age were the four most commonly involved covariates influencing VPA clearance. The model proposed by Serrano et al. showed the best performance with a median prediction error (MDPE) of 1.40%, median absolute prediction error (MAPE) of 17.38%, and percentages of PE within 20% (F(20), 55.69%) and 30% (F(30), 76.47%). However, all models performed inadequately in terms of the simulation-based normalized prediction distribution error, indicating unsatisfactory normality. Bayesian forecasting enhanced predictive performance, as prior observations were available. More prior observations are needed for model predictability to reach a stable state. The linear non-saturable binding equation had a higher predictive value than other protein binding models. Conclusion: The predictive abilities of most popPK models of VPA in children with epilepsy were unsatisfactory. The linear non-saturable binding equation is more suitable for modeling non-linearity. Moreover, Bayesian forecasting with prior observations improved model fitness.
format Online
Article
Text
id pubmed-10587682
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105876822023-10-21 Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study Zhang, Lina Liu, Maochang Qin, Weiwei Shi, Dandan Mao, Junjun Li, Zeyun Front Pharmacol Pharmacology Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predictive abilities of pediatric popPK models of VPA and identified the potential effects of protein binding modeling strategies. Methods: A dataset of 255 trough concentrations in 202 children with epilepsy was analyzed to assess the predictive performance of qualified models, following literature review. The evaluation of external predictive ability was conducted by prediction- and simulation-based diagnostics as well as Bayesian forecasting. Furthermore, five popPK models with different protein binding modeling strategies were developed to investigate the discrepancy among the one-binding site model, Langmuir equation, dose-dependent maximum effect model, linear non-saturable binding equation and the simple exponent model on model predictive ability. Results: Ten popPK models were identified in the literature. Co-medication, body weight, daily dose, and age were the four most commonly involved covariates influencing VPA clearance. The model proposed by Serrano et al. showed the best performance with a median prediction error (MDPE) of 1.40%, median absolute prediction error (MAPE) of 17.38%, and percentages of PE within 20% (F(20), 55.69%) and 30% (F(30), 76.47%). However, all models performed inadequately in terms of the simulation-based normalized prediction distribution error, indicating unsatisfactory normality. Bayesian forecasting enhanced predictive performance, as prior observations were available. More prior observations are needed for model predictability to reach a stable state. The linear non-saturable binding equation had a higher predictive value than other protein binding models. Conclusion: The predictive abilities of most popPK models of VPA in children with epilepsy were unsatisfactory. The linear non-saturable binding equation is more suitable for modeling non-linearity. Moreover, Bayesian forecasting with prior observations improved model fitness. Frontiers Media S.A. 2023-10-06 /pmc/articles/PMC10587682/ /pubmed/37869748 http://dx.doi.org/10.3389/fphar.2023.1228641 Text en Copyright © 2023 Zhang, Liu, Qin, Shi, Mao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Lina
Liu, Maochang
Qin, Weiwei
Shi, Dandan
Mao, Junjun
Li, Zeyun
Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title_full Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title_fullStr Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title_full_unstemmed Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title_short Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
title_sort modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587682/
https://www.ncbi.nlm.nih.gov/pubmed/37869748
http://dx.doi.org/10.3389/fphar.2023.1228641
work_keys_str_mv AT zhanglina modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy
AT liumaochang modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy
AT qinweiwei modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy
AT shidandan modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy
AT maojunjun modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy
AT lizeyun modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy